Daniel Gruskin is currently the SVP and Head of Global Medical Affairs at Ultragenyx, a position held since 2025. They previously served as Head of Medical Affairs at KalVista Pharmaceuticals, Inc. from 2024 to 2025, and have held various leadership roles within Genzyme, including VP and Head of North America Medical Affairs from 2013 to 2014. With a strong foundation in academia as an Assistant Professor of Human Genetics and Pediatrics at Emory University from 2003 to 2007, Daniel has built a significant career in medical affairs and clinical development, leading teams focused on rare diseases and data generation across multiple organizations. Daniel earned a BS from the University of Florida and an MD from the Medical College of Georgia School of Medicine.
Location
Boston, United States
This person is not in any teams
This person is not in any offices